HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method. - Wikidata - wikimedia - TriplyDB

HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.

HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.

http://www.wikidata.org/entity/Q37582166

about

Targeted nonviral gene therapy in prostate cancer Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth

P2860

Q57492228-E9DDCD5F-46E0-4339-B1DD-5405B2E12EB0 Q58728275-BE911D0F-6BE6-4FA3-9CA1-EADD838202C9

P2860

HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.

http://www.wikidata.org/entity/Q37582166

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.

@en

HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.

@nl

type

label

HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.

@en

HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.

@nl

prefLabel

HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.

@en

HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.

@nl

P1433

Q37582166-8D92BF02-D962-489D-912E-935D1B341315

P1476

Q37582166-0AA44C97-1650-41F0-B74D-662AEB526FAE

P2093

Q37582166-2D6885AE-F164-4CE9-8ACE-B741C5A356FC

Q37582166-67A21F23-9A8E-43BC-9088-BABE26B1BE9A

Q37582166-75EC045F-C6B7-429A-BEFA-DEAC61B38E37

Q37582166-7652632D-0276-4C5A-AB8B-B8B59A6A8FBE

Q37582166-7B9908F5-7856-4640-803B-F62FF085F88C

Q37582166-A16263FA-3F57-4ACC-9E10-B34DEBD2DD94

Q37582166-F46F3797-1C0B-40E5-81C6-D6F65B5119A5

Q37582166-FF01AC55-1EF4-48DB-8A9D-307E0A7F0075

P2860

Q37582166-035F7F34-CF3C-4DCA-96D8-58CA4BECF662

Q37582166-083A83CC-619A-4A10-A841-CCFE12B98906

Q37582166-0A4EA019-4823-4770-9441-4730ECF1C2ED

Q37582166-0ADDD127-FFD2-4EA5-8278-727A3B0F4726

Q37582166-0B9F4C0E-3A8B-42D7-A6CB-82A67685C5D0

Q37582166-10EF58F9-2AE4-483D-90CF-33C48E9345DE

Q37582166-129EA795-686A-4A16-8365-2F002D2FC1B8

Q37582166-12EED8B5-C9C1-458E-B77A-9EBB97613300

Q37582166-147CB52A-AF97-4FC7-94C6-49EC27249B52

Q37582166-1845B3CC-48B8-4337-BE57-C5437AAC2330

P304

Q37582166-248E7138-5964-457C-9396-06AC925AC461

P31

Q37582166-8C82897C-51E2-4A9F-A19D-742C5C524962

P356

Q37582166-69EC7944-7273-43E6-9C19-9C87CD995A11

P433

Q37582166-1979AD3B-9CF0-4870-A945-0C1DE119C238

P478

Q37582166-F079DC22-D4C1-4E5B-8D1A-F0411AA494D4

P50

Q37582166-C545FCCF-08CE-48CB-A1C3-2782922C8D41

P577

Q37582166-02E1FDA0-B783-4798-A0E7-2C0539260375

P698

Q37582166-09DF4FAA-B974-4ACC-A973-2F2453AD95E1

P932

Q37582166-2D9642A4-277D-46D1-B2D4-225AB50A4165

P356

P1433

Oncology Letters

P1476

HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.

@en

P2093

Abbas Shakoori

http://www.w3.org/2001/XMLSchema#string

Abolfazl Nesaei Bajestani

http://www.w3.org/2001/XMLSchema#string

Malihe Khaleghiyan

http://www.w3.org/2001/XMLSchema#string

Mansour Jamali

http://www.w3.org/2001/XMLSchema#string

Mehrdad Asghari Estiar

http://www.w3.org/2001/XMLSchema#string

Mohammad Reza Nowroozi

http://www.w3.org/2001/XMLSchema#string

Nazanin Sharifi

http://www.w3.org/2001/XMLSchema#string

Samira Ferdosi

http://www.w3.org/2001/XMLSchema#string

P2860

Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer

Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas

HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity

PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy

Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.

Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environment.

P304

4651-4658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.5235

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Arash Salmaninejad

P577

2016-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28105172

http://www.w3.org/2001/XMLSchema#string

P932

5228419

http://www.w3.org/2001/XMLSchema#string